Hypoglycaemia during pregnancy in women with Type 1 diabetes

Diabetic Medicine

Volumn 29, Issue 5, 2012, Pages 558-566

  Ringholm, L ^a,b   Pedersen Bjergaard, U ^c   Thorsteinsson, B ^c,d   Damm, P ^a,b,d   Mathiesen, E R ^a,b,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

HbA 1c; Hypoglycaemia; Hypoglycaemia awareness; Pregnancy; Type 1 diabetes

Indexed keywords

C PEPTIDE; CARBOHYDRATE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCAGON; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; PLACENTAL GROWTH FACTOR; SOMATOMEDIN C;

AWARENESS; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CELL FUNCTION; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INCIDENCE; INJECTION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MEAL; MEDICAL HISTORY; METABOLIC REGULATION; NAUSEA AND VOMITING; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; TREATMENT INDICATION;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; PREGNANCY; PREGNANCY IN DIABETICS; RISK FACTORS;

EID: 84859833625     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03604.x     Document Type: Review

References (84)

1. Boulot P, Chabbert-Buffet N, d'Ercole C, Floriot M, Fontaine P, Fournier A et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003; 26: 2990-2993.
2. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. Br Med J 1997; 315: 275-278.
3. 1c predicts preterm delivery in type1 diabetes. J Diabetes Complications 2008; 22: 297-302.
4. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type1 diabetes: nationwide prospective study in the Netherlands. Br Med J 2004; 328: 915.
5. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M et al. Outcomes in type1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004; 27: 2819-2823.
6. Lapolla A, Dalfra MG, Spezia R, Anichini R, Bonomo M, Bruttomesso D et al. Outcome of pregnancy in type1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol 2008; 45: 61-66.
7. Lauenborg J, Mathiesen E, Ovesen P, Westergaard JG, Ekbom P, Molsted-Pedersen L et al. Audit on stillbirths in women with pregestational type1 diabetes. Diabetes Care 2003; 26: 1385-1389.
8. Penney GC, Mair G, Pearson DW. Outcomes of pregnancies in women with type1 diabetes in Scotland: a national population-based study. BJOG 2003; 110: 315-318.
9. Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990; 7: 360.
10. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 271-286.
11. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245-1249.
12. Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995; 85: 417-422.
13. Evers IM, ter Braak EW, de Valk HW, van Der SB, Janssen N, Visser GH. Risk indicators predictive for severe hypoglycemia during the first trimester of type1 diabetic pregnancy. Diabetes Care 2002; 25: 554-559.
14. Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Johansen M, Damm P, Mathiesen ER. Hypoglycemia in pregnant women with type1 diabetes: predictors and role of metabolic control. Diabetes Care 2008; 31: 9-14.
15. Kimmerle R, Heinemann L, Delecki A, Berger M. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of typeI diabetic women. Diabetes Care 1992; 15: 1034-1037.
16. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV et al. Severe hypoglycaemia in 1076 adult patients with type1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004; 20: 479-486.
17. Ringholm NL, Juul A, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER. Lower levels of circulating IGF-I in Type1 diabetic women with frequent severe hypoglycaemia during pregnancy. Diabet Med 2008; 25: 826-833.
18. Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S et al. Maternal glycemic control and hypoglycemia in Type1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007; 30: 771-776.
19. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 90: 450-459.
20. Hellmuth E, Damm P, Molsted-Pedersen L, Bendtson I. Prevalence of nocturnal hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus. Acta Obstet Gynecol Scand 2000; 79: 958-962.
21. Schopman JE, Geddes J, Frier BM. Frequency of symptomatic and asymptomatic hypoglycaemia in Type1 diabetes: effect of impaired awareness of hypoglycaemia. Diabet Med 2011; 28: 352-355.
22. Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type1 diabetes. Diabetes Metab Res Rev 2003; 19: 232-240.
23. Diamond MP, Reece EA, Caprio S, Jones TW, Amiel S, DeGennaro N et al. Impairment of counter-regulatory hormone responses to hypoglycemia in pregnant women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 1992; 166: 70-77.
24. Rosenn BM, Miodovnik M, Khoury JC, Siddiqi TA. Counter-regulatory hormonal responses to hypoglycemia during pregnancy. Obstet Gynecol 1996; 87: 568-574.
25. ter Braak EW, Evers IM, Willem ED, Visser GH. Maternal hypoglycemia during pregnancy in type1 diabetes: maternal and fetal consequences. Diabetes Metab Res Rev 2002; 18: 96-105.
26. Bjorklund AO, Adamson UK, Carlstrom KA, Hennen G, Igout A, Lins PE et al. Placental hormones during induced hypoglycaemia in pregnant women with insulin-dependent diabetes mellitus: evidence of an active role for placenta in hormonal counter-regulation. Br J Obstet Gynaecol 1998; 105: 649-655.
27. Chellakooty M, Vangsgaard K, Larsen T, Scheike T, Falck-Larsen J, Legarth J et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 2004; 89: 384-391.
28. Fuglsang J, Lauszus F, Flyvbjerg A, Ovesen P. Human placental growth hormone, insulin-like growth factorI and -II, and insulin requirements during pregnancy in type1 diabetes. J Clin Endocrinol Metab 2003; 88: 4355-4361.
29. Lonberg U, Damm P, Andersson AM, Main KM, Chellakooty M, Lauenborg J et al. Increase in maternal placental growth hormone during pregnancy and disappearance during parturition in normal and growth hormone-deficient pregnancies. Am J Obstet Gynecol 2003; 188: 247-251.
30. Caufriez A, Frankenne F, Hennen G, Copinschi G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 1993; 265: E572-E577.
31. Caufriez A, Frankenne F, Englert Y, Golstein J, Cantraine F, Hennen G et al. Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol 1990; 258: E1014-E1019.
32. Madsbad S, Hilsted J, Krarup T, Sestoft L, Christensen NJ, Faber OK et al. Hormonal, metabolic and cardiovascular responses to hypoglycaemia in Type1 (insulin-dependent) diabetes with and without residual B-cell function. Diabetologia 1982; 23: 499-503.
33. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type1 diabetes mellitus. Lancet 2001; 357: 1248-1253.
34. Ilic S, Jovanovic L, Wollitzer AO. Is the paradoxical first trimester drop in insulin requirement due to an increase in C-peptide concentration in pregnant TypeI diabetic women? Diabetologia 2000; 43: 1329-1330.
35. Nielsen LR, Rehfeld JF, Pedersen-Bjergaard U, Damm P, Mathiesen ER. Pregnancy-induced rise in serum C-peptide concentrations in women with type1 diabetes. Diabetes Care 2009; 32: 1052-1057.
36. Pirttiaho HI, Hartikainen-Sorri AL, Kaapa P, Kaila JM, Puukka R. Maternal residual beta-cell function and the outcome of diabetic pregnancy. J Perinat Med 1987; 15: 83-89.
37. Montgomery H, Clarkson P, Barnard M, Bell J, Brynes A, Dollery C et al. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 1999; 353: 541-545.
38. Nordfeldt S, Samuelsson U. Serum ACE predicts severe hypoglycemia in children and adolescents with type1 diabetes. Diabetes Care 2003; 26: 274-278.
39. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type1 diabetes. Diabetologia 2003; 46: 89-96.
40. Pedersen-Bjergaard U, Dhamrait SS, Sethi AA, Frandsen E, Nordestgaard BG, Montgomery HE et al. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type1 diabetes. Am J Med 2008; 121: 246-248.
41. Zammitt NN, Geddes J, Warren RE, Marioni R, Ashby JP, Frier BM. Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type1 diabetes: does a relationship exist? Diabet Med 2007; 24: 1449-1454.
42. Pedersen-Bjergaard U, Thomsen CE, Hogenhaven H, Smed A, Kjaer TW, Holst JJ et al. Angiotensin-converting enzyme activity and cognitive impairment during hypoglycaemia in healthy humans. J Renin Angiotensin Aldosterone Syst 2008; 9: 37-48.
43. Itskovitz J, Rubattu S, Levron J, Sealey JE. Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy. J Clin Endocrinol Metab 1992; 75: 906-910.
44. Nielsen AH, Schauser KH, Poulsen K. Current topic: the uteroplacental renin-angiotensin system. Placenta 2000; 21: 468-477.
45. Al KH, Nasrat H, Broughton PF. A prospective, longitudinal study of the renin-angiotensin system, prostacyclin and thromboxane in the first trimester of normal human pregnancy: association with birthweight. Hum Reprod 2005; 20: 3157-3162.
46. Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August P, Thaler I et al. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab 1994; 79: 258-264.
47. Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Boomsma F, Damm P, Mathiesen ER. Severe hypoglycaemia during pregnancy in women with type1 diabetes: possible role of renin-angiotensin system activity? Diabetes Res Clin Pract 2009; 84: 61-67.
48. Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B. Classification of hypoglycemia awareness in people with type1 diabetes in clinical practice. J Diabetes Complications 2010; 24: 392-397.
49. Robertson H, Pearson DW, Gold AE. Severe hypoglycaemia during pregnancy in women with Type1 diabetes is common and planning pregnancy does not decrease the risk. Diabet Med 2009; 26: 824-826.
50. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 Type1 diabetic patients. Diabet Med 1991; 8: 217-222.
51. Jorgensen HV, Pedersen-Bjergaard U, Rasmussen AK, Borch-Johnsen K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type1 diabetes. Diabetes Care 2003; 26: 1106-1109.
52. Leinonen PJ, Hiilesmaa VK, Kaaja RJ, Teramo KA. Maternal mortality in type1 diabetes. Diabetes Care 2001; 24: 1501-1502.
53. An Advisory Board to the Driving Licence Committee of the European Union. Diabetes and Driving in Europe. A Report of the Second European Working Group on Diabetes and Driving. 2006. Available at Last accessed 12 February 2012.
54. Buchanan TA, Schemmer JK, Freinkel N. Embryotoxic effects of brief maternal insulin-hypoglycemia during organogenesis in the rat. J Clin Invest 1986; 78: 643-649.
55. Smoak IW, Sadler TW. Embryopathic effects of short-term exposure to hypoglycemia in mouse embryos in vitro. Am J Obstet Gynecol 1990; 163: 619-624.
56. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 1996; 174: 1343-1353.
57. Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009; 32: 38-44.
58. Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J et al. High prevalence of type2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008; 31: 340-346.
59. Weiss PA, Scholz HS, Haas J, Tamussino KF, Seissler J, Borkenstein MH. Long-term follow-up of infants of mothers with type1 diabetes: evidence for hereditary and non-hereditary transmission of diabetes and precursors. Diabetes Care 2000; 23: 905-911.
60. Nielsen GL, Dethlefsen C, Sorensen HT, Pedersen JF, Molsted-Pedersen L. Cognitive function and army rejection rate in young adult male offspring of women with diabetes: a Danish population-based cohort study. Diabetes Care 2007; 30: 2827-2831.
61. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med 1991; 325: 911-916.
62. Clausen TD, Mortensen EL, Schmidt L, Mathiesen ER, Hansen T, Jensen DM et al. Cognitive function in adult offspring of women with Type1 diabetes. Diabet Med 2011; 28: 838-844.
63. Garcia-Patterson A, Gich I, Amini SB, Catalano PM, de LA, Corcoy R. Insulin requirements throughout pregnancy in women with type1 diabetes mellitus: three changes of direction. Diabetologia 2010; 53: 446-451.
64. Jovanovic L, Knopp RH, Brown Z, Conley MR, Park E, Mills JL et al. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care 2001; 24: 1130-1136.
65. Atkin SL, Lindow SW, Walton C, Masson EA. Recurrent hypoglycaemia associated with first and second trimester insulin sensitivity in a patient with insulin-dependent diabetes. Diabet Med 1996; 13: 589-591.
66. Temple RC, Aldridge VJ, Murphy HR. Pre-pregnancy care and pregnancy outcomes in women with type1 diabetes. Diabetes Care 2006; 29: 1744-1749.
67. Heller SR, Colagiuri S, Vaaler S, Wolffenbuttel BH, Koelendorf K, Friberg HH et al. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type1 diabetes. Diabet Med 2004; 21: 769-775.
68. Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type1 diabetes. A meta-analysis. Diabetes Obes Metab 2009; 11: 372-378.
69. Garcia-Dominguez M, Herranz L, Hillman N, Martin-Vaquero P, Janez M, Moya-Chimenti E et al. Use of insulin lispro during pregnancy in women with pregestational diabetes mellitus. Med Clin (Barc) 2011; 137: 581-586.
70. Heller S, Damm P, Mersebach H, Skjoth TV, Kaaja R, Hod M et al. Hypoglycemia in type1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study. Diabetes Care 2010; 33: 473-477.
71. Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with Type1 diabetes. Diabet Med 2008; 25: 165-169.
72. Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A et al. Use of glargine in pregnant women with type1 diabetes mellitus: a case-control study. Clin Ther 2008; 30: 1476-1484.
73. Lapolla A, Di CG, Bruttomesso D, Dalfra MG, Fresa R, Mello G et al. Use of insulin detemir in pregnancy: a report on 10 Type1 diabetic women. Diabet Med 2009; 26: 1181-1182.
74. Mathiesen ER, Damm P, Hod M, McCance DR, Ivanisevic M, Garcia S et al. Maternal Glycaemic Control and Hypoglycaemia in Pregnancy: a randomized trial comparing insulin detemir with NPH insulin in 310 subjects with type1 diabetes. Diabetologia 2011; 54: S486.
75. Poyhonen-Alho M, Ronnemaa T, Saltevo J, Ekblad U, Kaaja RJ. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand 2007; 86: 1171-1174.
76. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in typeI diabetes. Diabetes Care 1996; 19: 324-327.
77. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type1 diabetes during real-time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. Br Med J 2011; 343: d3805.
78. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. Br Med J 2008; 337: a1680.
79. Murphy HR, Rayman G, Duffield K, Lewis KS, Kelly S, Johal B et al. Changes in the glycemic profiles of women with type1 and type2 diabetes during pregnancy. Diabetes Care 2007; 30: 2785-2791.
80. Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G et al. Closed-loop insulin delivery during pregnancy complicated by type1 diabetes. Diabetes Care 2011; 34: 406-411.
81. Worm D, Nielsen LR, Mathiesen ER, Norgaard K. Continuous glucose monitoring system with an alarm: a tool to reduce hypoglycemic episodes in pregnancy with diabetes. Diabetes Care 2006; 29: 2759-2760.
82. Chico A, Saigi I, Garcia-Patterson A, Santos MD, Adelantado JM, Ginovart G et al. Glycemic control and perinatal outcomes of pregnancies complicated by type1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin. Diabetes Technol Ther 2010; 12: 937-945.
83. Coustan DR, Reece EA, Sherwin RS, Rudolf MC, Bates SE, Sockin SM et al. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. J Am Med Assoc 1986; 255: 631-636.
84. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. Br Med J 2008; 336: 714-717.